Age, Sex Not As Predictive Of Severity Of MS, Study Shows
Two fundamental concepts in MS, that male gender and older age of onset contribute to more severe symptoms, do not appear to be accurate, according to a study published in the Jan. 24 issue of the journal Neurology.
For the study, researchers reviewed a database of 2,837 patients with MS and symptom onset before July 1988. The researchers used… read more »
Single Workout Improves Mood In Patients With Depression, Study Shows
Even one 30-minute exercise session is effective at improving some feelings of depression in patients with major depressive disorder, according to data from a recent study.
For the study, which was published in the December issue of the journal Medicine & Science in Sports & Exercise, researchers randomized 40 participants who were receiving treatment for major depressive disorder to either… read more »
Mental disorders associated with multiple sclerosis
Summary.
Gadolinium
Deep tendon reflexes
9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.
Retinoic acid (RA) regulates a wide range of biologic process, including inflammation. Previously, Retinoic Acid was shown to inhibit the clinical signs of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). The current study investigated the effects of 9-cis-RA (Retinoic Acid) on primary mouse microglia and astrocytes… read more »
BETHESDA, MD — February 2006
Bristol-Myers Squibb Co. announced labelling changes for Tequin (gatifloxacin), an antibiotic indicated for the treatment of patients with pneumonia, bronchitis, uncomplicated gonorrhea, and various infections including infections
